Distinct adipocyte size profiles and progenitor cell signatures underlie orbital adipose tissue expansion in Graves' orbitopathy
Abstract Background Graves' orbitopathy (GO) is characterized by expansion of orbital adipose tissue (OAT), causing proptosis and, in severe cases, compressive optic neuropathy. However, the adipocyte size profile and adipose progenitor cell (APC) heterogeneity underlying depot-specific OAT expansion remain poorly defined. Methods We compared adipocyte morphology and APCs (CD45⁻CD31 − CD34⁺ cells) in OAT from patients with GO (n = 33) and abdominal subcutaneous adipose tissue (SAT) from controls without GO (n = 10–17). APC subsets were characterized by flow cytometry using CD31, CD55, CD36, CD271, and MSCA1. Within the GO cohort, adipocyte size and progenitor subsets were related to demographic and clinical measures (EUGOGO classification, clinical activity score, TSH-receptor antibody (TRAb) status, Hertel exophthalmometry and Gorman diplopia score) using unsupervised clustering and stratification. Results OAT adipocytes were significantly smaller than abdominal SAT adipocytes. The APC fraction was reduced in OAT, with lower expression of CD34, CD36, MSCA1, and CD271, but increased CD55 positivity compared with SAT. Adipocyte size and SVF composition identified distinct demographic and clinical patterns. Larger adipocytes were associated with older age whereas smaller adipocytes were linked to greater disease activity/severity and TRAb positivity. A cell cluster enriched in CD55⁺ progenitor subset was associated with greater proptosis (Hertel ≥ 23 mm). Conclusions GO OAT displays a distinct adipocyte and progenitor phenotype. A CD55-enriched, CD36/MSCA1-low progenitor subset is associated with clinical proptosis while smaller adipocytes characterize more active/severe disease, suggesting hyperplastic OAT expansion during active GO and a shift toward hypertrophy with aging and inactive GO. These findings identify CD55⁺ orbital APCs as potential contributors to GO pathogenesis and candidate biomarkers or therapeutic targets.
Authors
- Pauline Decaunes
- Pénélope Viana (ORCID: https://orcid.org/0000-0003-0098-4831)
- Céline Dekeister
- Benoit Chaput (ORCID: https://orcid.org/0000-0002-8567-3479)
- Jean Galitzky (ORCID: https://orcid.org/0000-0001-6905-3547)
- Solange Grunenwald (ORCID: https://orcid.org/0000-0002-6174-448X)
- Anne Bouloumié (ORCID: https://orcid.org/0000-0001-5496-8891)
- Philippe Imbert
- Philippe Caron
Institutions
- Inserm (FR)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-16
- DOI
- https://doi.org/10.21203/rs.3.rs-11161746/v1
- Primary Topic
- Ophthalmology and Eye Disorders
- Type
- preprint